301 related articles for article (PubMed ID: 9728328)
21. Application of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in cultured skin fibroblasts from sphingolipidosis patients.
Fujiwaki T; Yamaguchi S; Sukegawa K; Taketomi T
Brain Dev; 2002 Apr; 24(3):170-3. PubMed ID: 11934514
[TBL] [Abstract][Full Text] [Related]
22. The genetics of sphingolipid hydrolases and sphingolipid storage diseases.
Schuchman EH; Simonaro CM
Handb Exp Pharmacol; 2013; (215):3-32. PubMed ID: 23579447
[TBL] [Abstract][Full Text] [Related]
23. Recent advances and novel treatments for sphingolipidoses.
Arenz C
Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617
[TBL] [Abstract][Full Text] [Related]
24. Sphingolipid signalling in the cardiovascular system: good, bad or both?
Alewijnse AE; Peters SL
Eur J Pharmacol; 2008 May; 585(2-3):292-302. PubMed ID: 18420192
[TBL] [Abstract][Full Text] [Related]
25. Sphingolipid signaling in epidermal homeostasis. Current knowledge and new therapeutic approaches in dermatology.
Geilen CC; Barz S; Bektas M
Skin Pharmacol Appl Skin Physiol; 2001; 14(5):261-71. PubMed ID: 11586067
[TBL] [Abstract][Full Text] [Related]
26. Sphingolipid signalling and liver diseases.
Marí M; Fernández-Checa JC
Liver Int; 2007 May; 27(4):440-50. PubMed ID: 17403183
[TBL] [Abstract][Full Text] [Related]
27. [Sphingolipid and apoptosis].
Wang J; Hu XS; Shi JP
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466
[TBL] [Abstract][Full Text] [Related]
28. Tandem Mass Spectrometry of Sphingolipids: Applications for Diagnosis of Sphingolipidoses.
Kuchař L; Asfaw B; Rybová J; Ledvinová J
Adv Clin Chem; 2016; 77():177-219. PubMed ID: 27717417
[TBL] [Abstract][Full Text] [Related]
29. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
30. [Sphingolipid storage diseases of the central nervous system: bases of biochemical and clinical heterogeneity].
Sandhoff K; Quintern L
Naturwissenschaften; 1988 Mar; 75(3):123-31. PubMed ID: 3132618
[TBL] [Abstract][Full Text] [Related]
31. The effect of altered sphingolipid acyl chain length on various disease models.
Park WJ; Park JW
Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
[TBL] [Abstract][Full Text] [Related]
32. The interplay between bioactive sphingolipids and steroid hormones.
Lucki NC; Sewer MB
Steroids; 2010 Jun; 75(6):390-9. PubMed ID: 20138078
[TBL] [Abstract][Full Text] [Related]
33. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
Sandhoff K
Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
[TBL] [Abstract][Full Text] [Related]
34. Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.
Chen H; Chan AY; Stone DU; Mandal NA
Surv Ophthalmol; 2014; 59(1):64-76. PubMed ID: 24011710
[TBL] [Abstract][Full Text] [Related]
35. Aberrant TGFβ Signalling Contributes to Dysregulation of Sphingolipid Metabolism in Intrauterine Growth Restriction.
Chauvin S; Yinon Y; Xu J; Ermini L; Sallais J; Tagliaferro A; Todros T; Post M; Caniggia I
J Clin Endocrinol Metab; 2015 Jul; 100(7):E986-96. PubMed ID: 25942476
[TBL] [Abstract][Full Text] [Related]
36. Gene Therapy of Sphingolipid Metabolic Disorders.
Shaimardanova AA; Solovyeva VV; Issa SS; Rizvanov AA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835039
[TBL] [Abstract][Full Text] [Related]
37. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
39. Sphingolipids and Lipoproteins in Health and Metabolic Disorders.
Iqbal J; Walsh MT; Hammad SM; Hussain MM
Trends Endocrinol Metab; 2017 Jul; 28(7):506-518. PubMed ID: 28462811
[TBL] [Abstract][Full Text] [Related]
40. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
Norris GH; Blesso CN
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
